Načítá se...
A meta-analysis of the efficacy and safety of adjuvant sorafenib for hepatocellular carcinoma after resection
BACKGROUND: Sorafenib was reported as a useful adjuvant treatment in patients with hepatocellular carcinoma who underwent surgical resection. However, its therapeutic value remains controversial. This meta-analysis examined the available data regarding the efficacy and safety of sorafenib in patient...
Uloženo v:
| Vydáno v: | World J Surg Oncol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8194151/ https://ncbi.nlm.nih.gov/pubmed/34112190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-021-02280-9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|